FDA lifts hold on trials of gene therapies for sickle cell disease, beta-thalassemia

The FDA subsequently placed a hold on trials of betibeglogene autotemcel, an autologous gene therapy that uses the same lentiviral vector (BB305) ...
https://www.google.com/url?rct=j&sa=t&url=https://www.healio.com/news/hematology-oncology/20210611/fda-lifts-hold-on-trials-of-gene-therapies-for-sickle-cell-disease-betathalassemia&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNFTmCt3UWnddYo2Oyjzw2RLSlac4Q